薬物動態
Print ISSN : 0916-1139
6-Amidino-2-naphthyl 4-[(4,5-dihydro-1H-imidazol-2-yl)amino]benzoate dimethanesulfonate (FUT-187)の体内動態に関する研究(第4報):ラットにおける未変化体および主代謝物の分離分析
小松 信三畔取 政行岩本 里美杉山 哲資渋谷 正興川口 安郎
著者情報
ジャーナル フリー

1992 年 7 巻 2 号 p. 203-212

詳細
抄録

6-Amidino-2-naphthyl 4-[(4, 5-dihydro-1H-imidazol-2-yl)amino]benzoate dimethanesulfonate (FUT-187), a novel protease inhibitor, is a ester of 4-[(4, 5-dihydro-1H-imidazol-2-yl)amino]benzoic acid (IABA) and 6-amidino-2-naphthol (AN). The metabolism of FUT-187 was studied after a single oral administration of [14C-IABA] FUT-187 or [14C-AN] FUT-187 to male rats at a dose of 30mg/kg.
1. Major metabolite of FUT-187 after oral administration of [14C-IABA] FUT-187 was IABA Dresent in the urine. feces and bile.
Only a small quantitiies of the unchanged FUT-187 were found in excreta. Minor metabolites, i.e., IABA glucuronide was found in urine.
2. Major metabolite of FUT-187 after oral administration of [14C-AN] FUT-187 were found to be AN-glucuronide and AN in the urine, feaces, bile, blood, liver, kidney and pancreas.
3. The concentrations of unchanged FUT-187, which is strongly related to its efficacy were 10 ?? 111 times higher in the liver, kidney, lung and pancreas than those in the blood.

著者関連情報
© 日本薬物動態学会
前の記事 次の記事
feedback
Top